These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37713176)

  • 1. Revisiting Cytomegalovirus Serology in Allogeneic Hematopoietic Cell Transplant Recipients.
    Portillo V; Masouridi-Levrat S; Royston L; Yerly S; Schibler M; Mappoura M; Morin S; Giannotti F; Mamez AC; van Delden C; Chalandon Y; Neofytos D
    Clin Infect Dis; 2024 Feb; 78(2):423-429. PubMed ID: 37713176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reexploring cytomegalovirus serology in allogeneic hematopoietic cell transplantation.
    Royston L; Neofytos D
    Curr Opin Infect Dis; 2024 Aug; 37(4):264-269. PubMed ID: 38861267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Features of cytomegalovirus DNAemia and virus-specific T-cell responses in allogeneic hematopoietic stem-cell transplant recipients during prophylaxis with letermovir.
    Giménez E; Guerreiro M; Torres I; Aguilar C; Albert E; Hernández-Boluda JC; Hernani R; Pérez A; Amat P; Piñana JL; Montoro J; Solano C; Navarro D
    Transpl Infect Dis; 2023 Apr; 25(2):e14021. PubMed ID: 36748748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics of inflammatory biomarkers in plasma predict the occurrence and features of cytomegalovirus DNAemia episodes in allogeneic hematopoietic stem cell transplant recipients.
    Talaya A; Giménez E; Vinuesa V; Pérez A; Amat P; Piñana JL; Albert E; Hernández-Boluda JC; Solano C; Navarro D
    Med Microbiol Immunol; 2019 Aug; 208(3-4):405-414. PubMed ID: 30911925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spontaneously-resolving episodes of cytomegalovirus DNAemia in allogeneic hematopoietic stem cell transplant recipients: Virological features and clinical outcomes.
    Talaya A; Giménez E; Piñana JL; Albert E; Hernández-Boluda JC; Pérez A; Torres I; Solano C; Navarro D
    J Med Virol; 2019 Jun; 91(6):1128-1135. PubMed ID: 30735250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring of oral cytomegalovirus DNA shedding for the prediction of viral DNAemia in allogeneic hematopoietic stem cell transplant recipients.
    Pascual T; Solano C; Torres I; Talaya A; Giménez E; Vinuesa V; Piñana JL; Hernández-Boluda JC; Pérez A; Navarro D
    J Med Virol; 2018 Aug; 90(8):1375-1382. PubMed ID: 29663435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CMV-IgG pre-allogeneic hematopoietic stem cell transplantation and the risk for CMV reactivation and mortality.
    Eberhardt KA; Jung V; Knops E; Heger E; Wirtz M; Steger G; Kaiser R; Affeldt P; Holtick U; Klein F; Scheid C; Di Cristanziano V
    Bone Marrow Transplant; 2023 Jun; 58(6):639-646. PubMed ID: 36869190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An investigation of the utility of plasma Cytomegalovirus (CMV) microRNA detection to predict CMV DNAemia in allogeneic hematopoietic stem cell transplant recipients.
    Talaya A; Giménez E; Pascual MJ; Gago B; Piñana JL; Hernández-Boluda JC; Vázquez L; García M; Serrano D; Hernández M; Albert E; Solano C; Navarro D
    Med Microbiol Immunol; 2020 Feb; 209(1):15-21. PubMed ID: 31478067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of cytomegalovirus (CMV) seroconversion pre-allogeneic hematopoietic cell transplantation on posttransplant outcomes.
    Sayyed A; Wilson L; Stavi V; Chen S; Chen C; Mattsson J; Lipton JH; Kim DD; Viswabandya A; Kumar R; Lam W; Law AD; Gerbitz A; Pasic I; Novitzky-Basso I; Mazzulli T; Michelis FV
    Eur J Haematol; 2024 Oct; 113(4):441-453. PubMed ID: 38880946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Letermovir for primary and secondary cytomegalovirus prevention in allogeneic hematopoietic cell transplant recipients: Real-world experience.
    Lin A; Maloy M; Su Y; Bhatt V; DeRespiris L; Griffin M; Lau C; Proli A; Barker J; Shaffer B; Giralt SA; Jakubowski AA; Papadopoulos EB; Papanicolaou GA; Seo SK; Perales MA
    Transpl Infect Dis; 2019 Dec; 21(6):e13187. PubMed ID: 31585500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Features of Cytomegalovirus DNAemia Blips in Allogeneic Hematopoietic Stem Cell Transplant Recipients: Implications for Optimization of Preemptive Antiviral Therapy Strategies.
    Huntley D; Talaya A; Giménez E; Martínez A; Hernández-Boluda JC; Hernani R; Torres I; Alberola J; Albert E; Piñana JL; Solano C; Navarro D
    Biol Blood Marrow Transplant; 2020 May; 26(5):972-977. PubMed ID: 32007638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of cytomegalovirus infection on post-transplant hospitalization days among children undergoing allogeneic hematopoietic cell transplantation: A marginal structural model approach.
    Li Y; Vader DT; Oganisian A; Boge CLK; Hayes M; Newman A; Olson T; Freedman J; Elgarten CW; Fisher BT
    Pediatr Transplant; 2024 Feb; 28(1):e14526. PubMed ID: 37550269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Sirolimus Exposure on the Need for Preemptive Antiviral Therapy for Cytomeglovirus Infection after Allogeneic Hematopoietic Stem Cell Transplantation.
    Guglieri-Lopez B; Perez-Pitarch A; Garcia-Cadenas I; Gimenez E; Barba P; Rabella N; Hernandez-Boluda JC; Fox L; Valcarcel D; Esquirol A; Ferriols-Lisart R; Sierra J; Solano C; Navarro D; Martino R; Piñana JL
    Biol Blood Marrow Transplant; 2019 May; 25(5):1022-1030. PubMed ID: 30639821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of Cytomegalovirus Reactivation by Recipient Cytomegalovirus-IgG Titer before Allogeneic Hematopoietic Stem Cell Transplantation.
    Kawamura S; Nakasone H; Takeshita J; Kimura SI; Nakamura Y; Kawamura M; Yoshino N; Misaki Y; Yoshimura K; Matsumi S; Gomyo A; Akahoshi Y; Kusuda M; Kameda K; Tanihara A; Tamaki M; Kako S; Kanda Y
    Transplant Cell Ther; 2021 Aug; 27(8):683.e1-683.e7. PubMed ID: 33984537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Letermovir for Cytomegalovirus prophylaxis in pediatric hematopoietic stem cell transplantation.
    Chen TT; David AP; Barthelmess EK; MacBrayne CE
    Pediatr Blood Cancer; 2023 Nov; 70(11):e30608. PubMed ID: 37548491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcomes of allogeneic hematopoietic stem cell transplant recipients developing Cytomegalovirus DNAemia prior to engraftment.
    Solano C; Vázquez L; Giménez E; de la Cámara R; Albert E; Rovira M; Espigado I; Calvo CM; López-Jiménez J; Suárez-Lledó M; Chinea A; Esquirol A; Pérez A; Bermúdez A; Saldaña R; Heras I; González-Huerta AJ; Torrado T; Batlle M; Jiménez S; Vallejo C; Barba P; Cuesta MÁ; Piñana JL; Navarro D;
    Bone Marrow Transplant; 2021 Jun; 56(6):1281-1290. PubMed ID: 33319853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytomegalovirus DNAemia and risk of mortality in allogeneic hematopoietic stem cell transplantation: Analysis from the Spanish Hematopoietic Transplantation and Cell Therapy Group.
    Solano C; Vázquez L; Giménez E; de la Cámara R; Albert E; Rovira M; Espigado I; Calvo CM; López-Jiménez J; Suárez-Lledó M; Chinea A; Esquirol A; Pérez A; Bermúdez A; Saldaña R; Heras I; González-Huerta AJ; Torrado T; Bautista G; Batlle M; Jiménez S; Vallejo C; Barba P; Cuesta MÁ; Piñana JL; Navarro D
    Am J Transplant; 2021 Jan; 21(1):258-271. PubMed ID: 32812351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and economic impact of treated CMV infection in adult CMV-seropositive patients after allogeneic hematopoietic cell transplantation.
    Peffault De Latour R; Chevallier P; Blaise D; Alami S; Lévy-Bachelot L; Allavoine T; Tadmouri A; Blomkvist J; Duhamel A; Srour M; Beauvais D; Yakoub-Agha I
    J Med Virol; 2020 Dec; 92(12):3665-3673. PubMed ID: 32297984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequent occurrence of cytomegalovirus retinitis during immune reconstitution warrants regular ophthalmic screening in high-risk pediatric allogeneic hematopoietic stem cell transplant recipients.
    Hiwarkar P; Gajdosova E; Qasim W; Worth A; Breuer J; Chiesa R; Ridout D; Edelsten C; Moore A; Amrolia P; Veys P; Rao K
    Clin Infect Dis; 2014 Jun; 58(12):1700-6. PubMed ID: 24700657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylactic letermovir decreases cytomegalovirus reactivation after stem cell transplantation: a single-center real-world evidence study.
    Serio B; Giudice V; Guariglia R; Fontana R; Pezzullo L; Martorelli MC; Ferrara I; Mettivier L; D'Addona M; Vaccaro E; Langella M; Selleri C
    Infez Med; 2021 Mar; 29(1):102-113. PubMed ID: 33664179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.